OMNIX MEDICAL
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
OMNIX MEDICAL
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.omnixmedical.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
14.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tal Ventures
Tal Ventures investment in Seed Round - Omnix Medical
National Institutes of Health
National Institutes of Health investment in Grant - Omnix Medical
European Innovation Council
European Innovation Council investment in Grant - Omnix Medical
VLX Ventures
VLX Ventures investment in Seed Round - Omnix Medical
Entrée Capital
Entrée Capital investment in Seed Round - Omnix Medical
Official Site Inspections
http://www.omnixmedical.com
- Host name: israel237.jetserver.net
- IP address: 81.218.117.77
- Location: Tel Aviv Israel
- Latitude: 32.0678
- Longitude: 34.7647
- Timezone: Asia/Jerusalem
More informations about "Omnix Medical"
Company - Omnix Medical
[email protected]; Linkedin Twitter. A-2-Z - Digital Accessibility and Marketing Omnix Medical Ltd. is committed to making its website and all its electronic information easier to use …See details»
Overview - Omnix Medical
COMPANY OVERVIEW Founded in 2015, Omnix Medical is a clinical-stage biopharmaceutical company developing an arsenal of novel antibiotic agents for the treatment of infections …See details»
Omnix Medical - Crunchbase Company Profile & Funding
Contact Email [email protected] Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and …See details»
Omnix Medical - LinkedIn
Omnix Medical | 1,517 followers on LinkedIn. Omnix Medical is dedicated to the development of novel antimicrobial pharmaceuticals against drug-resistant bacteria. | Omnix Medical is a clinical ...See details»
Omnix Medical Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Omnix Medical. Use the PitchBook Platform to explore the full profile.See details»
Omnix Medical - Devex
Learn more about Omnix Medical's jobs, projects, latest news, contact information and geographical presence. Founded in 2015, Omnix Medical is a clinical-stage biopharmaceutical …See details»
Omnix Medical Granted Fast-Track Designation by U.S. FDA for
Feb 20, 2024 Designation underlines the need for novel, first-in-class antimicrobials for the treatment of infections with Gram-negative bacteria. JERUSALEM, Israel, February 20, 2023 -- …See details»
Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its ...
- Phase I data show safety and tolerability at clinically significant dose levels- New class of anti-infectives to treat infections with Gram-negative bacteria JERUSALEM, Israel, November 20, …See details»
Omnix Medical Starts Phase I Clinical Trial of Novel - GlobeNewswire
Dec 4, 2022 [email protected]. Media Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Managing Partners [email protected] Tel. +49 40 88 16 59 64 / Tel. +49 30 23 …See details»
Omnix Medical Starts Phase I Clinical Trial of Novel Anti-Infective ...
Apr 12, 2022 - New mechanism of action (MoA) addressing global increase of antimicrobial resistance (AMR) burden and shortage of potent anti-infectives JERUSALEM, Israel, April 12, …See details»
Omnix Medical Granted Fast-Track Designation by U.S. FDA
Feb 20, 2024 [email protected]. Media Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Managing Partners [email protected] Tel. +49 40 88 16 59 64 / Tel. +49 30 23 …See details»
Pipeline - Omnix Medical
[email protected]; Linkedin Twitter. A-2-Z - Digital Accessibility and Marketing Omnix Medical Ltd. is committed to making its website and all its electronic information easier to use …See details»
Omnix Medical Starts Phase I Clinical Trial of their Novel ...
May 8, 2022 New mechanism of action (MoA) addressing global increase of antimicrobial resistance (AMR) burden and shortage of potent anti-infectives JERUSALEM, Israel, April XX, …See details»
Omnix Medical Receives U.S. FDA Approval of a Phase II
Nov 20, 2023 [email protected]. Media Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Managing Partners [email protected] Tel. +49 40 88 16 59 64 / Tel. +49 30 23 …See details»
Omnix Medical Announces Excellent Topline Data from the Phase I ...
May 8, 2023 - OMN6 demonstrates safety and tolerability at clinically significant dose levels JERUSALEM, Israel, May 8th, 2023 -- Omnix Medical, a biopharmaceutical company …See details»
Omnix News - Omnix Medical
[email protected]; Linkedin Twitter. A-2-Z - Digital Accessibility and Marketing Omnix Medical Ltd. is committed to making its website and all its electronic information easier to use …See details»
Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its ...
Nov 20, 2023 Corporate Contacts Moshik Cohen-Kutner, CEO +972-50-8698218. Niv Bachnoff, CSO +972-54-238-6023 [email protected]. Media Inquiries akampion Dr. Ludger …See details»
Technology - Omnix Medical
[email protected]; Linkedin Twitter. A-2-Z - Digital Accessibility and Marketing Omnix Medical Ltd. is committed to making its website and all its electronic information easier to use …See details»
Omnix Medical Announces Excellent Topline Data from the
May 8, 2023 [email protected]. Media Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Managing Partners [email protected] Tel. +49 40 88 16 59 64 / Tel. +49 30 23 …See details»